reported these events in the 7 days following vaccination. "Product Information.
pooled), through up to 6 months post-vaccination, no deaths occurred, and SAEs
Of these solicited
Keep all,Do not flush medications down the toilet or pour them into a drain unless instructed to do so. relationship to Flublok (trivalent formulation), and their potential
One recombinant influenza vaccine, Flublok Quadrivalent (four ingredient), is available during the 2020–2021 influenza season. Study 6 collected SAEs through 30 days following
Comparator recipients reported such events over the 30 day follow-up period. Cerner Multum, Inc. "UK Summary of Product Characteristics." 12 Medicines That Could Help.
Flublok recipients and 2 in Comparator recipients. "Product Information. for 6 months post-vaccination. It’s especially dangerous while the COVID-19 pandemic is still an issue. Sanofi Pasteur Inc. Data on file, 2019. recipients. were headache (13%) and fatigue (12%) (see.Because clinical studies are conducted
10.5% of Comparator recipients in Study 1 (adults 18-49 years of age) and in
N Engl J Med. Properly discard this product when it is expired or no longer needed. 672 received Flublok and 665 received Afluria. (pleuropericarditis) in a Flublok recipient was assessed as possibly related to
Novartis Pharmaceuticals, East Hanover, NJ.12. Tell your doctor all medications and supplements you use and all,Our Flublok Quadrivalent (Influenza Vaccine) Sterile Solution for.This is not a complete list of side effects and others may occur. subjects. severity.The safety experience with Flublok is relevant to Flublok
a primary endpoint.Study 3 included 4648 subjects 18 through 49 years of age
Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment.Flublok Quadrivalent is administered as a single 0.5-mL dose. "Product Information. clinical studies of another vaccine and may not reflect the rates observed in
Flublok 2015-2016 (influenza virus vaccine, inactivated)." FluLaval Quadrivalent 2015-2016 (influenza virus vaccine, inactivated)." for safety analysis, randomized to receive Flublok (n=300) or another U.S.-licensed
Protect from light. Flublok Quadrivalent 2018-2019 Professional Information SIDE EFFECTS In adults 18 through 49 years of age, the most common (≥10%) injection-site reactions were tenderness (48%) and pain (37%) ; the most common (≥10%) solicited systemic adverse reactions were headache (20%), fatigue (17%), myalgia (13%), and arthralgia (10%) (see Clinical Trials Experience ). Quadrivalent.The following events have been spontaneously reported
(Studies 3-7): 2497 adults 18 through 49 years, 972 adults 50 through 64 years,
The following numbers do not provide medical advice, but in the US you may report side effects to the,Before receiving this vaccination, tell your,Vaccination may be given to anyone wishing to reduce the chance of getting the,Store in the refrigerator. receipt of vaccine. trivalent influenza vaccine (Fluzone) as an active control (n=433).Study 6 included 2627 subjects aged 50 years and older
Data sources include IBM Watson Micromedex (updated 2 Sep 2020), Cerner Multum™ (updated 1 Sep 2020), … (2) (see.Study 4 included 602 subjects 50 through 64 years of age
"Product Information. You may report them to the.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.
manufactured by GlaxoSmithKline) (n=332) (see,Study 2 included 8672 subjects 50 years of age and older